These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22237257

  • 21. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M.
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [Abstract] [Full Text] [Related]

  • 22. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.
    Li C, Xia J, Deng J, Jiang J.
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):593-600. PubMed ID: 18432629
    [Abstract] [Full Text] [Related]

  • 23. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?
    Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, EU-ADR Consortium.
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):611-21. PubMed ID: 22315152
    [Abstract] [Full Text] [Related]

  • 24. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A, Durrieu G, Lapeyre-Mestre M, Montastruc JL, Association of French PharmacoVigilance Centres.
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [Abstract] [Full Text] [Related]

  • 25. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M, Bate A.
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [Abstract] [Full Text] [Related]

  • 26. Grouping the pharmacovigilance terms with a hybrid approach.
    Dupuch M, Dupuch L, Perinet A, Hamon T, Grabar N.
    Stud Health Technol Inform; 2012 Apr; 180():235-9. PubMed ID: 22874187
    [Abstract] [Full Text] [Related]

  • 27. Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm.
    Shin H, Cha J, Lee Y, Kim JY, Lee S.
    Health Informatics J; 2021 Apr; 27(3):14604582211033014. PubMed ID: 34289723
    [Abstract] [Full Text] [Related]

  • 28. Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance.
    Duclos C, Soualmia LF, Krivine S, Jamet A, Lillo-Louët A.
    Stud Health Technol Inform; 2010 Apr; 160(Pt 2):1005-9. PubMed ID: 20841835
    [Abstract] [Full Text] [Related]

  • 29. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL, Lopes P, Nunes T, Campos D, Boyer S, Ahlberg E, van Mulligen EM, Kors JA, Singh B, Furlong LI, Sanz F, Bauer-Mehren A, Carrascosa MC, Mestres J, Avillach P, Diallo G, Díaz Acedo C, van der Lei J.
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [Abstract] [Full Text] [Related]

  • 30. Machine learning model combining features from algorithms with different analytical methodologies to detect laboratory-event-related adverse drug reaction signals.
    Jeong E, Park N, Choi Y, Park RW, Yoon D.
    PLoS One; 2018 May; 13(11):e0207749. PubMed ID: 30462745
    [Abstract] [Full Text] [Related]

  • 31. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
    Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
    [Abstract] [Full Text] [Related]

  • 32. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.
    Schuemie MJ.
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):292-9. PubMed ID: 20945505
    [Abstract] [Full Text] [Related]

  • 33. Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection.
    Patadia VK, Schuemie MJ, Coloma P, Herings R, van der Lei J, Straus S, Sturkenboom M, Trifirò G.
    Int J Clin Pharm; 2015 Feb; 37(1):94-104. PubMed ID: 25488315
    [Abstract] [Full Text] [Related]

  • 34. Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting.
    Miguel A, Azevedo LF, Lopes F, Freitas A, Pereira AC.
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):98-102. PubMed ID: 23027707
    [Abstract] [Full Text] [Related]

  • 35. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection.
    Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE.
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):496-502. PubMed ID: 23412832
    [Abstract] [Full Text] [Related]

  • 36. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL, Lugardon S, Desboeuf K, Fernet P, Lapeyre-Mestre M.
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [Abstract] [Full Text] [Related]

  • 37. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.
    Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T.
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):289-96. PubMed ID: 22139991
    [Abstract] [Full Text] [Related]

  • 38. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
    Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, Fourrier-Réglat A, Molokhia M, Patadia V, van der Lei J, Sturkenboom M, Trifirò G.
    Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
    [Abstract] [Full Text] [Related]

  • 39. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
    Bate A, Lindquist M, Orre R, Edwards IR, Meyboom RH.
    Eur J Clin Pharmacol; 2002 Oct; 58(7):483-90. PubMed ID: 12389072
    [Abstract] [Full Text] [Related]

  • 40. Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002).
    West SL, D'Aloisio AA, Ringel-Kulka T, Waller AE, Clayton Bordley W.
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1255-67. PubMed ID: 17918773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.